Cargando…
Albumin binding ligands and albumin conjugate uptake by cancer cells
The scope of this short review is to summarise the knowledge gleaned from the fate of drugs transported by albumin upon contact with the target cancer cell or cells in inflamed tissues. The authors expertise covers covalently bound drugs and their cellular uptake and release from albumin. This revie...
Autor principal: | Frei, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3133998/ https://www.ncbi.nlm.nih.gov/pubmed/21676260 http://dx.doi.org/10.1186/1758-5996-3-11 |
Ejemplares similares
-
Albumin-Binding Domain Conjugate for Near-Infrared Fluorescence Lymphatic Imaging
por: Davies-Venn, Cynthia A., et al.
Publicado: (2011) -
Serum Albumin–Peptide
Conjugates for Simultaneous Heparin Binding and Detection
por: Liu, Qing, et al.
Publicado: (2019) -
Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA)
por: Taguchi, Yasuto, et al.
Publicado: (2004) -
Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy
por: Sasaki, Koichi, et al.
Publicado: (2019) -
Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy
por: Yang, Jincheng, et al.
Publicado: (2018)